does pfizer make glp 1 drugs Phase IIb Data Support Monthly GLP-1 Dosing for Obesity A Monthly Weight Loss Shot?

In March 2026, Structure reported 44-week topline data from the ACCESS II Phase 2 study, showing placebo-adjusted weight loss of up to 16.3%, which the company described as the highest efficacy demonstrated among oral GLP-1 receptor agonists at that time point

Apply the patch to the abdomen and press genlly for at least 3 seconds3

Feeling fuller can lead to reduced caloric intake and improved glucose tolerance

And despite their popularity, many Americans face barriers to accessing these treatments due to high costs and limited insurance coverage

Therefore, women of childbearing age should be advised that significant weight loss may increase fertility, requiring effective contraception

J Clin Invest 101(7):14211430